Cargando…

Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19

Adrenal insufficiency (AI) is a life-threatening disorder, with increased morbidity and mortality, especially in case of an acute illness that can increase the requirement of cortisol. A novel infectious disease, termed Coronavirus Disease 2019 (COVID-19), appeared in 2020. Therefore, AI patients ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabbadin, Chiara, Betterle, Corrado, Scaroni, Carla, Ceccato, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739913/
https://www.ncbi.nlm.nih.gov/pubmed/35002978
http://dx.doi.org/10.3389/fendo.2021.805647
_version_ 1784629203103121408
author Sabbadin, Chiara
Betterle, Corrado
Scaroni, Carla
Ceccato, Filippo
author_facet Sabbadin, Chiara
Betterle, Corrado
Scaroni, Carla
Ceccato, Filippo
author_sort Sabbadin, Chiara
collection PubMed
description Adrenal insufficiency (AI) is a life-threatening disorder, with increased morbidity and mortality, especially in case of an acute illness that can increase the requirement of cortisol. A novel infectious disease, termed Coronavirus Disease 2019 (COVID-19), appeared in 2020. Therefore, AI patients are experiencing a novel challenge: the risk of infection. In our experience, a prompt contact to the Endocrine center (with a telemedicine consultation) and a full awareness of diseases (cortisol deficiency, COVID-19 and the self-management of an adrenal crisis) are important to motivate patients. Vaccine is an effective treatment to prevent hospitalization and aggressive course of COVID-19. Some patients manifest challenges due to inequitable access and vaccine hesitancy, resulting in a delay in the acceptance of vaccines despite the availability of vaccination services. Therefore, an effort of all physicians must be conducted in order to advise patients with AI. In this short review, we try to answer some frequently asked questions regarding the management of patients with AI.
format Online
Article
Text
id pubmed-8739913
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87399132022-01-08 Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19 Sabbadin, Chiara Betterle, Corrado Scaroni, Carla Ceccato, Filippo Front Endocrinol (Lausanne) Endocrinology Adrenal insufficiency (AI) is a life-threatening disorder, with increased morbidity and mortality, especially in case of an acute illness that can increase the requirement of cortisol. A novel infectious disease, termed Coronavirus Disease 2019 (COVID-19), appeared in 2020. Therefore, AI patients are experiencing a novel challenge: the risk of infection. In our experience, a prompt contact to the Endocrine center (with a telemedicine consultation) and a full awareness of diseases (cortisol deficiency, COVID-19 and the self-management of an adrenal crisis) are important to motivate patients. Vaccine is an effective treatment to prevent hospitalization and aggressive course of COVID-19. Some patients manifest challenges due to inequitable access and vaccine hesitancy, resulting in a delay in the acceptance of vaccines despite the availability of vaccination services. Therefore, an effort of all physicians must be conducted in order to advise patients with AI. In this short review, we try to answer some frequently asked questions regarding the management of patients with AI. Frontiers Media S.A. 2021-12-24 /pmc/articles/PMC8739913/ /pubmed/35002978 http://dx.doi.org/10.3389/fendo.2021.805647 Text en Copyright © 2021 Sabbadin, Betterle, Scaroni and Ceccato https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Sabbadin, Chiara
Betterle, Corrado
Scaroni, Carla
Ceccato, Filippo
Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19
title Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19
title_full Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19
title_fullStr Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19
title_full_unstemmed Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19
title_short Frequently Asked Questions in Patients With Adrenal Insufficiency in the Time of COVID-19
title_sort frequently asked questions in patients with adrenal insufficiency in the time of covid-19
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739913/
https://www.ncbi.nlm.nih.gov/pubmed/35002978
http://dx.doi.org/10.3389/fendo.2021.805647
work_keys_str_mv AT sabbadinchiara frequentlyaskedquestionsinpatientswithadrenalinsufficiencyinthetimeofcovid19
AT betterlecorrado frequentlyaskedquestionsinpatientswithadrenalinsufficiencyinthetimeofcovid19
AT scaronicarla frequentlyaskedquestionsinpatientswithadrenalinsufficiencyinthetimeofcovid19
AT ceccatofilippo frequentlyaskedquestionsinpatientswithadrenalinsufficiencyinthetimeofcovid19